中粮科技(000930) - 2024 Q1 - 季度财报

Financial Performance - Total operating revenue for the current period reached ¥4,731,528,010.13, an increase from ¥4,522,104,000.26 in the previous period, representing a growth of approximately 4.63%[1] - Total operating costs amounted to ¥4,609,751,181.02, compared to ¥4,510,275,709.94 in the prior period, reflecting an increase of about 2.66%[1] - Net profit for the current period was ¥24,640,657.00, significantly up from ¥3,617,226.21 in the previous period, indicating a growth of approximately 582.56%[4] - Basic earnings per share increased to ¥0.0134 from ¥0.0008, marking a substantial rise of 1,575%[6] - Other income for the current period was ¥10,720,888.76, up from ¥9,045,836.49, indicating an increase of approximately 18.54%[4] - Net profit attributable to shareholders was ¥24,840,311.23, a significant increase of 1,613.02% from ¥1,450,089.28 year-on-year[26] - The weighted average return on equity was 0.24%, up from 0.01% in the previous year[26] Cash Flow - Cash inflow from operating activities totaled ¥5,929,009,821.95, down from ¥6,453,391,228.69 in the previous period, a decrease of about 8.09%[7] - Cash outflow from operating activities was ¥7,343,594,351.67, compared to ¥9,134,605,592.15 in the prior period, showing a decrease of approximately 19.63%[7] - The net cash flow from operating activities improved by 47.24%, amounting to -¥1,414,584,529.72 compared to -¥2,681,214,363.46 in the previous year[31] - The net cash flow from investing activities was -280,692,622.61, a decline from -231,346,407.87 in the prior period[38] - Cash inflow from financing activities totaled 2,740,258,981.40, down from 3,693,238,000.00 in the previous period[38] - The net cash flow from financing activities was 1,504,712,206.77, significantly lower than 3,042,507,094.32 in the prior period[38] - The cash and cash equivalents at the end of the period amounted to 1,264,274,022.80, compared to 1,145,935,878.88 at the end of the previous period[38] Assets and Liabilities - The total assets of COFCO Biotech reached RMB 18,053,837,163.20, an increase from RMB 16,557,861,385.94 in the previous period, reflecting a growth of approximately 9.0%[19] - Current assets totaled RMB 7,616,694,519.53, up from RMB 6,035,315,718.36, indicating a growth of about 26.3%[19] - The total liabilities amounted to RMB 6,726,048,170.02, up from RMB 5,141,805,247.60, indicating an increase of approximately 31.0%[19] - The company's non-current assets totaled RMB 10,437,142,643.67, a slight decrease from RMB 10,522,545,667.58, reflecting a decline of about 0.8%[19] - The total equity attributable to shareholders was ¥10,419,474,802.16, a slight decrease of 0.31% from ¥10,451,611,345.75[26] Research and Development - Research and development expenses increased to ¥30,614,055.85 from ¥25,614,065.15, representing a growth of about 19.06%[1] - The company's R&D expenses increased by 19.52% to ¥30,614,055.85, up from ¥25,614,065.15 in the same period last year[31] Shareholder Information - The company reported no significant changes in the top 10 shareholders' financing activities during the period[14] - COFCO Biotech's major shareholder, COFCO Bio-chemical Investment Co., Ltd., holds a significant stake without any reported related party transactions[14] - The company had a total of 117,703 common shareholders at the end of the reporting period[32] Inventory and Borrowings - Inventory increased significantly to RMB 3,399,208,050.24 from RMB 2,534,268,489.13, representing a growth of around 34.1%[19] - Short-term borrowings rose to RMB 4,772,971,429.85 from RMB 3,216,804,597.02, an increase of approximately 48.3%[19] Financial Changes - The company reported a decrease in financial expenses by 69.02%, amounting to ¥10,340,921.89, due to a reduction in loan scale[31] - The total comprehensive income attributable to the parent company was ¥-28,040,772.21, compared to ¥-7,978,934.33 in the prior period, reflecting a decline[6] - The impact of exchange rate changes on cash and cash equivalents was -24,207,445.69, contrasting with a positive impact of 409,736.55 in the previous period[38]